Business

Biotechs want to unlock the psychedelics market, but it isn’t simple

The huge boom of investor interest in psychedelics companies has been complicated by the tight regulations on the drugs and need for more evidence to flow through.

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business